Search Results - "Ortiz Romero, Pablo L"
-
1
The changing therapeutic landscape, burden of disease, and unmet needs in patients with cutaneous T‐cell lymphoma
Published in British journal of haematology (01-02-2021)“…Summary Cutaneous T‐cell lymphomas (CTCLs) have a chronic, relapsing course, and the most common subtypes are mycosis fungoides and Sézary syndrome. The…”
Get full text
Journal Article -
2
Intralesional brentuximab vedotin for the treatment of primary cutaneous T‐cell lymphomas: a case series
Published in International journal of dermatology (01-02-2024)Get full text
Journal Article -
3
Real‐life experience of using pegylated liposomal doxorubicin in primary cutaneous T‐cell lymphomas
Published in Clinical and experimental dermatology (01-09-2022)“…Mycosis fungoides (MF) is the most prevalent subtype of primary cutaneous T‐cell lymphomas (CTCLs). Sézary syndrome (SS) is another entity defined by leukaemic…”
Get full text
Journal Article -
4
Primary cutaneous anaplastic large‐cell lymphoma successfully treated with intralesional brentuximab vedotin: a case report
Published in International journal of dermatology (01-07-2022)Get full text
Journal Article -
5
-
6
Romidepsin‐induced sterile folliculitis in a patient with Sézary syndrome
Published in International journal of dermatology (01-04-2022)Get full text
Journal Article -
7
Rapidly‐developing alopecic nodules in a young man
Published in International journal of dermatology (01-10-2020)Get full text
Journal Article -
8
Psoriatic alopecia‐like paradoxical reaction to certolizumab pegol
Published in International journal of dermatology (01-06-2019)Get full text
Journal Article -
9
EORTC, ISCL, and USCLC consensus recommendations for the treatment of primary cutaneous CD30-positive lymphoproliferative disorders: lymphomatoid papulosis and primary cutaneous anaplastic large-cell lymphoma
Published in Blood (13-10-2011)“…Primary cutaneous CD30+ lymphoproliferative disorders (CD30+ LPDs) are the second most common form of cutaneous T-cell lymphomas and include lymphomatoid…”
Get full text
Journal Article -
10
MicroRNAs as prognostic markers in indolent primary cutaneous B-cell lymphoma
Published in Modern pathology (01-02-2013)“…Indolent primary cutaneous B-cell lymphoma is a group of malignant lymphomas comprising marginal zone B-cell lymphoma and centrofollicular B-cell lymphoma…”
Get full text
Journal Article -
11
p62/SQSTM1 Fuels Melanoma Progression by Opposing mRNA Decay of a Selective Set of Pro-metastatic Factors
Published in Cancer cell (14-01-2019)“…Modulators of mRNA stability are not well understood in melanoma, an aggressive tumor with complex changes in the transcriptome. Here we report the ability of…”
Get full text
Journal Article -
12
MicroRNA Expression Profiling and DNA Methylation Signature for Deregulated MicroRNA in Cutaneous T-Cell Lymphoma
Published in Journal of investigative dermatology (01-04-2015)“…MicroRNAs usually regulate gene expression negatively, and aberrant expression has been involved in the development of several types of cancers. Microarray…”
Get full text
Journal Article -
13
-
14
Gene Expression Profiling of Primary Cutaneous Melanoma and Clinical Outcome
Published in JNCI : Journal of the National Cancer Institute (05-04-2006)“…Background: Gene expression profiling data for human primary cutaneous melanomas are scarce because of the lack of retrospective collections of frozen tumors…”
Get full text
Journal Article -
15
Mycosis fungoides progression could be regulated by microRNAs
Published in PloS one (12-06-2018)“…Differentiating early mycosis fungoides (MF) from inflammatory dermatitis is a challenge. We compare the differential expression profile of early-stage MF…”
Get full text
Journal Article -
16
Association of APOA5 and APOC3 Genetic Polymorphisms With Severity of Hypertriglyceridemia in Patients With Cutaneous T-Cell Lymphoma Treated With Bexarotene
Published in JAMA dermatology (Chicago, Ill.) (01-12-2018)“…Hypertriglyceridemia is the most frequent and limiting adverse effect of bexarotene therapy in cutaneous T-cell lymphoma (CTCL). Despite standard prophylactic…”
Get more information
Journal Article -
17
The Course of Mycosis Fungoides under Cytokine Pathway Blockers: A Multicentre Analysis of Real-Life Clinical Data
Published in Acta dermato-venereologica (01-09-2020)“…Literature regarding the effect of biologics on the course of mycosis fungoides (MF) is scarce. This multicentre study analysed retrospective data on 19…”
Get full text
Journal Article -
18
The Circulating Transcriptome as a Source of Biomarkers for Melanoma
Published in Cancers (10-01-2019)“…The circulating transcriptome is a valuable source of cancer biomarkers, which, with the exception of microRNAs (miRNAs), remains relatively unexplored. To…”
Get full text
Journal Article -
19
Primary cutaneous marginal zone B-cell lymphoma: Response to treatment and disease-free survival in a series of 137 patients
Published in Journal of the American Academy of Dermatology (01-09-2013)“…Background Primary cutaneous marginal zone B-cell lymphomas are low-grade lymphomas running an indolent course. Skin relapses have been frequently reported but…”
Get full text
Journal Article -
20
DEK oncogene is overexpressed during melanoma progression
Published in Pigment cell and melanoma research (01-03-2017)“…Summary DEK is an oncoprotein involved in a variety of cellular functions, such as DNA repair, replication, and transcriptional control. DEK is preferentially…”
Get full text
Journal Article